Filter your results
- 2
- 1
- 3
- 3
- 2
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Killer immunoglobulin‐like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment‐free remissionCancer Medicine, 2019, 8 (11), pp.4976-4985. ⟨10.1002/cam4.2371⟩
Journal articles
hal-02395190v1
|
||
|
Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1‐driven acute lymphoblastic leukemiaMolecular Oncology, 2021, 15, pp.1412 - 1431. ⟨10.1002/1878-0261.12877⟩
Journal articles
hal-03408341v1
|
||
|
Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1‐driven acute lymphoblastic leukemiaMolecular Oncology, 2021, 15 (5), pp.1412-1431. ⟨10.1002/1878-0261.12877⟩
Journal articles
hal-03401225v1
|